Clinical Trial Detail

NCT ID NCT01783535
Title Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

retinoblastoma

Therapies

Cyclophosphamide

Carboplatin + Doxorubicin + Vincristine Sulfate

Pegfilgrastim

Topotecan + Vincristine Sulfate

Carboplatin + Etoposide + Vincristine Sulfate

Filgrastim

Carboplatin + Topotecan

Carboplatin + Vincristine Sulfate

Age Groups: adult child senior

No variant requirements are available.